Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seng Gee Lim

Showing results (201-210 of 241) with videos related to

Pageof 25
Sort By:
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation studyYu Jun Wong, Guan Sen Kew, Poh Seng Tan, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
World Journal of Gastroenterology|August 1, 2015
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsersWattana Sukeepaisarnjaroen, Tri Pham, Tewesak Tanwandee, et al.
Journal of Hepatology|May 10, 2017
Intrahepatic CD206<sup>+</sup> macrophages contribute to inflammation in advanced viral-related liver diseaseAlfonso Tan-Garcia, Lu-En Wai, Dahai Zheng, et al.
Hepatology Communications|November 9, 2020
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data ValidationDaniel Q Huang, Yee Hui Yeo, Eunice Tan, et al.
Clinical and Molecular Hepatology|January 8, 2024
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patientsJinlin Hou, Edward Gane, Rozalina Balabanska, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis BYoung-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)Seng Gee Lim, Wah Wah Phyo, Joanna Zhi Jie Ling, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Pageof 25

Showing results (201-210 of 241) with videos related to

Sort By:
Pageof 25
Clinics and Research in Hepatology and Gastroenterology|March 29, 2021
Novel albumin, bilirubin and platelet criteria for the exclusion of high-risk varices in compensated advanced chronic liver disease: A validation studyYu Jun Wong, Guan Sen Kew, Poh Seng Tan, et al.
Hepatology International|March 20, 2015
Reimbursement policies in the Asia-Pacific for chronic hepatitis BSeng Gee Lim, Deepak N Amarapurkar, Henry Lik-Yuen Chan, et al.
World Journal of Gastroenterology|August 1, 2015
Boceprevir early-access for advanced-fibrosis/cirrhosis in Asia-Pacific hepatitis C virus genotype 1 non-responders/relapsersWattana Sukeepaisarnjaroen, Tri Pham, Tewesak Tanwandee, et al.
Journal of Hepatology|May 10, 2017
Intrahepatic CD206<sup>+</sup> macrophages contribute to inflammation in advanced viral-related liver diseaseAlfonso Tan-Garcia, Lu-En Wai, Dahai Zheng, et al.
Hepatology Communications|November 9, 2020
ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data ValidationDaniel Q Huang, Yee Hui Yeo, Eunice Tan, et al.
Clinical and Molecular Hepatology|January 8, 2024
Efficacy, safety, and pharmacokinetics of capsid assembly modulator linvencorvir plus standard of care in chronic hepatitis B patientsJinlin Hou, Edward Gane, Rozalina Balabanska, et al.
Antiviral Research|April 19, 2024
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferonDaniel Q Huang, Liang Shen, Wah Wah Phyo, et al.
JHEP Reports : Innovation in Hepatology|September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis BYoung-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)Seng Gee Lim, Wah Wah Phyo, Joanna Zhi Jie Ling, et al.
Hepatology International|February 3, 2022
Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancyManoj Kumar, Zaigham Abbas, Milad Azami, et al.
Pageof 25